electroCore, Inc.

ECOR ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $32.0M $25.2M $16.0M $8.6M $5.5M $3.5M $2.4M $993.0K
Cost of Revenue $4.2M $3.8M $2.8M $1.6M $1.4M $1.7M $1.2M $578.7K
Gross Profit $27.8M $21.4M $13.2M $7.0M $4.1M $1.8M $1.2M $414.2K
Gross Margin 86.8% 85.0% 82.5% 81.2% 74.6% 50.3% 51.6% 41.7%
Operating Expenses
Research & Development — $2.4M $5.3M $5.5M $2.5M $4.2M $9.9M $12.5M
SG&A Expense $38.2M $31.2M $27.2M $24.3M $21.6M $21.8M $35.4M $42.5M
Operating Income $-13.2M $-12.2M $-19.3M $-22.9M $-20.0M $-24.7M $-46.1M $-54.6M
Operating Margin -41.1% -48.3% -120.2% -266.2% -367.7% -707.9% -1,928.2% -5,494.1%
Interest Expense $14.9K $18.4K — $4.0K — $341 $3.5K —
Pretax Income $-14.0M $-12.0M $-19.0M $-22.6M $-18.1M $-24.7M $-45.1M $-55.8M
Income Tax Expense $3.0K $-93.0K $-186.0K $-431.0K $-851.0K $-1.2M $17.7K $2.4K
Net Income $-14.0M $-11.9M $-18.8M $-22.2M $-17.2M $-23.5M $-45.1M $-55.8M
Net Margin -43.6% -47.2% -117.5% -257.9% -315.9% -672.5% -1,888.8% -5,621.7%
EPS (Basic) $-1.65 $-1.59 $-3.42 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $-1.65 $-1.59 $-3.42 $0.00 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 8.5K 7.5M 5.5M 5.5M 4.6M 53.12B 34.79B 34.34B
Shares Outstanding (Diluted) 8.5K 7.5M 5.5M 5.5M 4.6M 53.12B 34.79B 34.34B
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →